Espaņol (soon!) - October 6, 2008
CMEonHIV.com is dedicated to providing online CME presentations (slides with voiceover) on HIV/AIDS for healthcare professionals given by local and international experts to keep you up-to-date on the ongoing developments in the field.
  Biography  

Dr. Jose Gatell

Current Position
Head, Infectious Diseases & AIDS Units, Hospital Clinic
Professor of Medicine, University of Barcelona

Primary Area of Interest
AIDS, Infectious Diseases

Medical Training
Hospital Clinic, University of Barcelona

Post-Graduate Training
Hospital Clinic, University of Barcelona
Harvard Medical School, Boston

Current Boards or Associations
Past President, Spanish Society Infectious Diseases and Clinical Microbiology (SEIMC)
Past President, Catalan Society of Infectious Diseases
Vice-President, European AIDS Society
Co-Chair, XIV International AIDS Conference, Barcelona, July 2002

Memberships
Steering Committee, European Union Program

Recent Publications
- Garcia F, Plana M, Soriano A et al. The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection. AIDS 2001; 15:F29-F40.
- Garcia F, Plana M, Soriano A et al. Predictors of progression in chronically infected naive patients with plasma viral load below 5000 copies and CD4+ lymphocytes above 500. AIDS 2001; 15:131-3.
- Knobel H, Miro JM, Domingo P et al. Failure of short-term prednisone regimen to prevent nevirapine associated rash. A double blind placebo controlled clinical trial. GESIDA 09/99 Study. J Acquir Immune Defic Syndr 2001; In press.
- Lundgren J, Mocroft A, Gatell JM et al. A clinically prognostic scoring system for patients receiving HAART. J Infect Dis 2001; In press.
- A Practical Guide to Aids (6 editions) and A Practical Guide to Antimicrobial Therapy (11 editions)

Honours/Awards
Associate Editor: Clinical Infectious Diseases, Antiviral Therapy HIV Medicine, J AIDS
 
  List of presentations from this healthcare provider available on CMEonHIV :

Initiating Antiretroviral Therapy (Why, When and How to Initiate...
NEV/EFA/ABA Trial - SWITCHING PROTEASE INHIBITORS TO NEVIRAPINE, EFAVIRENZ...
Treatment Interruptions
Initial Therapy
ART Strategies in Stable & Virologically Suppressed Patients
Efficacy and Safety of Atazanavir (ATV)-Based HAART in Patients Switched...
Opening Ceremony
  Login

  Please log in and get access to thousands of resources about HIV disease and its treatment.
 
Already a member?
  Username :
  Password :
   
 
  Lost your password?


  Search our database
  Find the information that you are looking for in over +3000 resources.
 
web cmeonhiv.com



CMEonHIV is owned by E-MedHosting.com.

Copyright @ 2002-2008 E-MedHosting.com. All rights reserved.  Disclaimer  |  Sponsor Disclaimer


USER ACKNOWLEDGES AND AGREES THAT ALL DECISIONS MADE WITH THE ASSISTANCE OR USE OF THE SOFTWARE AND/OR THE WEBSITE AND/OR
BASED ON CONTENT FOUND HEREIN WILL BE EXCLUSIVELY THE RESPONSIBILITY OF THE USER.
C-Reactive Protein (CRP)